MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
C4 Therapeutics, Inc.

CCCC

#2959
C4 Therapeutics, Inc.
2.70
-1.46%
Sector:
Base:
Profit Currency:
Daily Range
2.70
2.70
Year Range
1.08
3.64
Daily Change
-1.46%
Monthly Change
+26.17%
6 month change
+5.06%
Year Change
+4.25%
Previous Close
2.74
Open
2.70
Bid
Ask
Low
2.70
High
2.70
Volume
57
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. CCCC
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM

News

Investing Investing
CCCC
2 days ago, 18:04
Barclays raises C4 Therapeutics stock price target on trial progress
Investing Investing
CCCC
2 days ago, 16:46
TD Cowen reiterates Buy rating on C4 Therapeutics stock
Investing Investing
CCCC
2 days ago, 14:08
C4 earnings beat by $0.11, revenue topped estimates
Investing Investing
CCCC
2026.02.23
Brookline Capital raises C4 Therapeutics stock price target on trial progress
Investing Investing
CCCC
2026.02.23
C4 Therapeutics doses first patient in phase 2 myeloma trial
Investing Investing
CCCC
2026.01.17
C4 Therapeutics’ chief medical officer Reyno sells $22,200 in stock
Investing Investing
CCCC
2026.01.14
C4 Therapeutics to advance cemsidomide trials for multiple myeloma
Investing Investing
CCCC
2025.12.02
C4 Therapeutics stock initiated with Buy rating at TD Cowen
Benzinga Benzinga
BL CCCC NET WFRD CRC
2025.12.02
This Cloudflare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - BlackLine (NASDAQ:BL), C4 Therapeutics (NASDAQ:CCCC)
Seeking Alpha Seeking Alpha
ESPR CCCC SITM MNDY INSP
2025.11.12
Wasatch Ultra Growth Fund Q3 2025 Top Contributors And Detractors
Investing Investing
CCCC
2025.11.06
C4 earnings missed by $0.03, revenue topped estimates
Zacks Zacks
CCCC
2025.11.06
C4 Therapeutics, Inc. (CCCC) Reports Q3 Loss, Beats Revenue Estimates

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd